p53 Gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas

Journal of Pathology

Volumn 190, Issue 4, 2000, Pages 417-422

  Shahnavaz, S A ^a   Regezi, J A ^b   Bradley, G ^a   Dube I D ^c   Jordan, Richard C K ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Carcinoma; Dysplasia; Gene; Oral; p53; Progression

Indexed keywords

PROTEIN P53;

ARTICLE; BIOPSY; CARCINOGENESIS; CLINICAL ARTICLE; EPITHELIUM DYSPLASIA; EXON; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

BIOPSY; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENES, P53; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; SEQUENCE ANALYSIS, DNA;

EID: 0034020520     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200003)190:4<417::AID-PATH544>3.0.CO;2-G     Document Type: Article

References (38)

1. MacDonald DG, Saka SM. Structural indicators of the high risk lesion. In Risk Markers for Oral Diseases, vol 2, Johnson NW (ed.). Cambridge University Press: Cambridge, 1991: 165-187.
2. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1995; 79: 321-329.
3. Silverman SJ, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53: 563-568.
4. Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol 1972; 33: 389-399.
5. Shepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol Eur J Cancer 1998; 34: 270-275.
6. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 94: 23-28.
7. Arnold A, Cossman J, Bishop JM, Bakhshi A, Korsmeyer SJ. The molecular genetics of cancer. Science 1987; 235: 305-311.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 757-767.
9. Greenblatt MS, Bennett WP, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
10. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-1602.
11. Lane DP. p53 and human cancers [Review]. Br Med Bull 1994; 50: 582-599.
12. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 1992; 166: 389-394.
13. Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 1993; 50: 426-429.
14. Piffko J, Bankfalvi A, Ofner D, Joos U, Bocker W, Schmid KW. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. J Pathol 1995; 176: 69-75.
15. Shintani S, Yoshihama Y, Emilio AR, Matsumura T. Over-expression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Anticancer Res 1995; 15: 305-308.
16. Wilson GD, Richman PI, Dische S, Robinson B, Daley FM, Ross DA. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. Br J Cancer 1995; 71: 1248-1252.
17. Shin DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54: 321-326.
18. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 1995; 24: 18-22.
19. Sauter ER, Cleveland D, Trock B, Ridge JA, Klein-Szanto AJ. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis 1994; 15: 2269-2274.
20. Girod SC, Pape HD, Krueger GR. p53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa. Oral Oncol Eur J Cancer Part B: 1994; 6: 419-423.
21. Kannan S, Chandran GJ, Pillai KR, et al. Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki-67. J Clin Pathol: Mol Pathol 1996; 49: 170-175.
22. Kaur J, Srivastava A, Ralhan R. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer 1994; 58: 340-345.
23. Kushner J, Bradley G, Jordan RC. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol 1997; 183: 418-423.
24. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-2492.
25. Macgeoch C, Barnes DM, Newton JA, et al. P53 protein detected by immunohistochemical staining is not always mutant. Dis Markers 1993; 11: 239-250.
26. Dowell SP, Ogden GR. The use of antigen retrieval for immunohistochemical detection of p53 overexpression in malignant and benign oral mucosa: a cautionary note. J Oral Pathol Med 1996; 25: 60-64.
27. Calzolari A, Chiarelli I, Bianchi S, et al. Immunohistochemical vs. molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol 1997; 107: 7-11.
28. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481
29. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477-4480.
30. Warnakulasuriya KA, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992; 21: 404-408.
31. Langdon JD, Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxfac Surg 1992; 30: 214-220.
32. el-Naggar AK, Lai S, Luna MA, et al. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Oncol (Pred Oncol) 1998; 64: 196-201.
33. Murti PR, Warnakulasuriya KA, Johnson NW, et al. p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 1998; 27: 191-196.
34. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 1998; 14: 272-276.
35. Li Y-Q, Pavelic ZP, Wang L-J, et al. Altered p53 in microdissected, metachronous, premalignant oral lesions from the same patients. J Clin Pathol: Mol Pathol 1995; 48: 269-272.
36. Speight PM, Morgan PR. The natural history and pathology of oral cancer and precancer. Community Dent Health 1993; 10 (Suppl 1): 31-41.
37. Banoczy J, Csiba A. Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol 1976; 42: 766-774.
38. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited. J Pathol 1994; 172: 1-4.